Treatment of severe preeclampsia remote from term: A clinical dilemma

Obstetrical and Gynecological Survey

Volumn 54, Issue 11, 1999, Pages 723-727

  Many, Ariel ^a,b   Kuperminc, Michael J ^a   Pausner, David ^a   Lessing, Joseph B ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b LIS MATERNITY HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; DEXAMETHASONE; HYDRALAZINE; LACTATE DEHYDROGENASE; LIVER ENZYME; NIFEDIPINE;

CLINICAL TRIAL; CONSERVATIVE TREATMENT; DISEASE SEVERITY; FEMALE; FETUS OUTCOME; HELLP SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PREECLAMPSIA; REVIEW; RISK;

ADRENAL CORTEX HORMONES; ADULT; ANTIHYPERTENSIVE AGENTS; FEMALE; HELLP SYNDROME; HUMANS; MATERNAL MORTALITY; PATIENT CARE PLANNING; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 0032756868     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199911000-00024     Document Type: Review

References (27)

1. Roberts JM, Redman CWG. Preeclampsia: More than pregnancy-induced hypertension. Lancet 1993;341:1447-1451.
2. Redman CWG, Roberts JM. Management of preeclampsia. Lancet 1993;341:1451-1454.
3. World Health Organization Study Group. The hypertensive disorders of pregnancy. WHO Technical Report Series no 758. Geneva: World Health Organization, 1987.
4. American College of Obstetricians and Gynecologists. Management of severe preeclampsia. Washington, DC: American College of Obstetricians and Gynecologists; 1986. Technical Bulletin 91.
5. Sibai BM, Spinnato JA, Watson DL et al. Pregnancy outcome in 303 cases with severe preeclampsia. Obstet Gynecol 1984; 64:319-323.
6. Dorfman SF. Maternal mortality in New York City, 1981-1983. Obstet Gynecol 1990;76:317-321.
7. Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994;309:1395-1400.
8. Chesly LC, Annitto JE, Cosgrove RA. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol 1976;124:446-451.
9. 4 therapy in preeclampsia-eclampsia. Obstet Gynecol 1981;57:199-202.
10. Roberts JM. Pregnancy-related hypertension. In: Creasy RK, Resnik R, eds. Maternal Fetal Medicine, Principles and Practice, 3rd Ed. Philadelphia: Saunders, 1994, pp 804-810.
11. Olah KS, Redman CW, Gee H. Management of severe, early preeclampsia: Is conservative management justified? Eur J Obstet Gynecol Reprod Biol 1993;51:175-180.
12. Sibai BM, Taslimi M, Abella TN et al. Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol 1985;152:32-37.
13. Moodley J, Koranteng SA, Rout C. Expectant management of early onset of severe pre-eclampsia in Durban. S Afr Med J 1993;83:584-587.
14. Odendaal HJ, Pattison RC, Bam R et al. Aggressive or expectant management for patients with severe preeclampsia between 28 and 34 weeks' gestation: A randomized controlled trial. Obstet Gynecol 1993;76:1070-1075.
15. Sibai BM, Mercer BM, Sciff E et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: A randomized controlled trial. Am J Obstet Gynecol 1994;171:818-822.
16. Fenakel K, Fenakel G, Appelman Z et al. Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991;77: 331-337.
17. Schiff E, Friedman SA, Lu K et al. The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol 1996;175:1313-1316.
18. Chua S, Redman CW. Prognosis for pre eclampsia complicated by 5 gram or more of proteinuria in 24 hours. Eur J Obstet Gynecol Reprod Biol 1992;43:9-12.
19. Schiff E, Friedman SA, Sibai BM. Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994;84:626-630.
20. Visser W, Wallenburg HC. Maternal and perinatal outcome of temporizing management in 254 consecutive patients with severe preeclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 1995;63:147-154.
21. Visser W, Wallenburg HC. Temporizing management of severe preeclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102:111-117.
22. Magann EF, Bass D, Chauhan SP et al. Antepartum cortico-steroids: Disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 1994;171:1148-1153.
23. Spinillo A, Capuzzo E, Stronati M et al. Early neonatal complications after elective preterm delivery in hypertensive pregnancies. J Perinat Med 1995;23:175-181.
24. Friedman SA, Schiff E, Kao L et al. Neonatal outcome after preterm delivery for preeclampsia. Am J Obstet Gynecol 1996;172:1785-1792.
25. Banias BB, Devoe LD, Nolan TE. Severe preeclampsia in preterm pregnancy between 26 and 32 weeks' gestation. Am J Perinatol 1992;9:357-360.
26. Kilpatrick SJ. Women with severe preeclampsia at >28 weeks gestation should be delivered. In: Hypertension in Pregnancy. SPO Special Interest Group 1995, Society of Perinatal Obstetricians, 15th Annual Meeting, Atlanta, GA.
27. Chari RS, Friedman SA, O'Brien JM et al. Daily antenatal testing in women with severe preeclampsia. Am J Obstet Gynecol 1995;173:1207-1210.